Lab Quality and Follow-Up in the New England Genetics Collaborative
Long-term follow-up to ensure quality care of individuals diagnosed with newborn screening conditions: early experience in New England
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm
Population-based research within a public health system; two models for common rule compliance in the Massachusetts Newborn Screening Program
Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care
Newborn Screening Showing Decreasing Incidence of Cystic Fibrosis
Spectrum of Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency detected by newborn screening.